AstraZeneca receives European regulatory approval for new version of … - Chicago Tribune
LONDON (AP) _ Pharmaceutical company AstraZeneca PLC said Thursday European regulators have approved a new version of its bipolar disorder drug Seroquel. The drug company said a once-daily formulation, Seroquel XR, has been approved by the European …